Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wieke M van Oostveen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|March 6, 2021
Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal MonitoringWieke M van Oostveen, Elizabeth C M de Lange
Immunological Reviews|September 9, 2024
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseasesWieke M van Oostveen, Tom W J Huizinga, Cynthia M Fehres
Scientific Reports|June 11, 2021
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitorsHubert J Sijben, Wieke M van Oostveen, Peter B R Hartog, et al.
Frontiers in Pharmacology|May 24, 2024
Label-free detection of prostaglandin transporter (SLCO2A1) function and inhibition: insights by wound healing and TRACT assaysTamara A M Mocking, Wieke M van Oostveen, Jacobus P D van Veldhoven, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 25, 2024
Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic SclerosisWieke M van Oostveen, Eva M Hoekstra, E W Nivine Levarht, et al.
RMD Open|October 16, 2025
Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosisKatherine E van der Wouden, Saad Ahmed, Wieke M van Oostveen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|March 6, 2021
Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal MonitoringWieke M van Oostveen, Elizabeth C M de Lange
Immunological Reviews|September 9, 2024
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseasesWieke M van Oostveen, Tom W J Huizinga, Cynthia M Fehres
Scientific Reports|June 11, 2021
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitorsHubert J Sijben, Wieke M van Oostveen, Peter B R Hartog, et al.
Frontiers in Pharmacology|May 24, 2024
Label-free detection of prostaglandin transporter (SLCO2A1) function and inhibition: insights by wound healing and TRACT assaysTamara A M Mocking, Wieke M van Oostveen, Jacobus P D van Veldhoven, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 25, 2024
Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic SclerosisWieke M van Oostveen, Eva M Hoekstra, E W Nivine Levarht, et al.
RMD Open|October 16, 2025
Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosisKatherine E van der Wouden, Saad Ahmed, Wieke M van Oostveen, et al.
Pageof 1